Clinical Scorecard: Can Digital Pathology Improve Risk Stratification After Prostatectomy?

At a Glance

Key Highlights

• MMAI model integrates digitized pathology slides with clinical variables
• 10-year AUC for distant metastasis prediction was 0.74 for MMAI model
• High-risk group showed a 10-year cumulative incidence of 25% for distant metastasis
• Validation performed on 533 patients with a median follow-up of nine years
• Prospective evaluation of the biomarker as a laboratory-developed test is underway

Guideline-Based Recommendations

Diagnosis

• Utilize MMAI model for improved risk stratification in BCR patients

Management

• Consider treatment differences based on MMAI risk classification

Monitoring & Follow-up

• Regular follow-up for patients categorized as high-risk

Risks

• Potential for distant metastasis based on MMAI score

Patient & Prescribing Data

Patients with biochemical recurrence post-prostatectomy

Outcomes vary based on treatment type and MMAI risk classification

Clinical Best Practices

• Incorporate digital pathology insights into clinical decision-making
• Review adverse morphologic patterns in pathology slides for risk assessment
• Use archived specimens for prognostic information beyond standard features

References

• European Urology Study